Comparison of Two Commercial Colorimetric Broth Microdilution Tests for <i>Candida</i> Susceptibility Testing: Sensititre YeastOne versus MICRONAUT-AM

Comparison of Two Commercial Colorimetric Broth Microdilution Tests for <i>Candida</i> Susceptibility Testing: Sensititre YeastOne versus MICRONAUT-AM

Two colorimetric broth microdilution antifungal susceptibility tests were compared, Sensititre YeastOne and MICRONAUT-AM for nine antifungal agents. One hundred clinical <i>Candida</i> isolates were tested, representing a realistic population for susceptibility testing in daily practice....

Full description

Bibliographic Details
Main Authors:	Sophie Philips, Frederik Van Hoecke, Emmanuel De Laere, Steven Vervaeke, Roos De Smedt, Jerina Boelens, Deborah De Geyter, Denis Piérard, Katrien Lagrou
Format:	Article
Language:	English
Published:	MDPI AG 2021-05-01
Series:	Journal of Fungi
Subjects:	<i>Candida</i> antifungal agents antifungal susceptibility testing colorimetry CLSI EUCAST
Online Access:	https://www.mdpi.com/2309-608X/7/5/356

Similar Items

<i>Aspergillus</i> Section <i>Terrei</i> and Antifungals: From Broth to Agar-Based Susceptibility Testing Methods
by: Roya Vahedi-Shahandashti, et al.
Published: (2023-02-01)

Comparison between EUCAST Broth Microdilution and MIC Strip Test in Defining Isavuconazole In Vitro Susceptibility against <i>Candida</i> and Rare Yeast Clinical Isolates
by: Maddalena Calvo, et al.
Published: (2023-01-01)

Comparative evaluation of sensititre YeastOne and VITEK2 antifungal susceptibility tests with CLSI broth microdilution method of clinical Cryptococcus isolates in Taiwan
by: Tzu-Ping Weng, et al.
Published: (2025-02-01)

Comparison of the Micronaut-AM System and the EUCAST Broth Microdilution Reference Method for MIC Determination of Four Antifungals against <i>Aspergillus fumigatus</i>
by: Nikolett Gyurtane Szabo, et al.
Published: (2023-06-01)

Evaluation of Etest and MICRONAUT-AM Assay for Antifungal Susceptibility Testing of <i>Candida auris</i>: Underestimation of Fluconazole Resistance by MICRONAUT-AM and Overestimation of Amphotericin B Resistance by Etest
by: Mohammad Asadzadeh, et al.
Published: (2024-09-01)

Evaluation of the Sensititre YeastOne and Etest in Comparison with CLSI M38-A2 for Antifungal Susceptibility Testing of Three Azoles, Amphotericin B, Caspofungin, and Anidulafungin, against <i>Aspergillus</i><i>fumigatus</i> and Other Species, Using New Clinical Breakpoints and Epidemiological Cutoff Values
by: Marcia S. C. Melhem, et al.
Published: (2022-10-01)

In Vitro Azole and Amphotericin B Susceptibilities of <i>Malassezia furfur</i> from Bloodstream Infections Using E-Test and CLSI Broth Microdilution Methods
by: Wafa Rhimi, et al.
Published: (2020-06-01)

Antifungal Resistance in Cryptococcal Infections
by: Marcia S. C. Melhem, et al.
Published: (2024-01-01)

Comparison of the VITEK 2 Yeast Antifungal Susceptibility Testing with CLSI Broth Microdilution Reference Method for Testing Four Antifungal Drugs against Candida species Isolated from Blood Samples
by: Vijaya S. Rajmane, et al.
Published: (2018-01-01)

<i>Aeromonas dhakensis</i>: Clinical Isolates with High Carbapenem Resistance
by: Suat Moi Puah, et al.
Published: (2022-07-01)

SUSCEPTIBILITY OF Candida spp. ISOLATED FROM BLOOD CULTURES AS EVALUATED USING THE M27-A3 AND NEW M27-S4 APPROVED BREAKPOINTS
by: Edileusa Rosa dos Santos, et al.
Published: (2014-12-01)

Overestimation of Amphotericin B Resistance in Candida auris with Sensititre YeastOne Antifungal Susceptibility Testing: a Need for Adjustment for Correct Interpretation
by: Maria Siopi, et al.
Published: (2023-06-01)

A Comparative Prospective Study in Evaluating <i>Candida</i> spp. In Vitro Susceptibility through Micronaut-AM and Sensititre Yeast-One
by: Laura Trovato, et al.
Published: (2023-08-01)

Novel Antifungals and <i>Aspergillus</i> Section <i>Terrei</i> with Potpourri Susceptibility Profiles to Conventional Antifungals
by: Roya Vahedi-Shahandashti, et al.
Published: (2023-06-01)

Comparison of the ATB® Fungus 2 with the AFST-EUCAST for in vitro susceptibility testing of Candida spp
by: Jehidys Estella Montiel Ramos, et al.
Published: (2014-04-01)

Genotyping Analysis of <i>Cryptococcus deuterogattii</i> and Correlation with Virulence Factors and Antifungal Susceptibility by the Clinical and Laboratory Standards Institute and the European Committee on Antifungal Susceptibility Testing Methods
by: Leonardo Euripedes Andrade-Silva, et al.
Published: (2023-08-01)

Dermatophyte susceptibilities to antifungal azole agents tested in vitro by broth macro and microdilution methods Suscetibilidade in vitro de dermatófitos a azóis pelos métodos macro e microdiluição em caldo
by: Emerson Roberto Siqueira, et al.
Published: (2008-02-01)

The Influence of Medium Composition on EUCAST and Etest Antifungal Susceptibility Testing
by: Roya Vahedi-Shahandashti, et al.
Published: (2023-09-01)

Synergistic In Vitro Interaction of Isavuconazole and Isoquercitrin against <i>Candida glabrata</i>
by: Petra V. Schwarz, et al.
Published: (2022-05-01)

Comparison between E-test and CLSI broth microdilution method for antifungal susceptibility testing of Candida albicans oral isolates Comparação entre E-test e o método da microdiluição do CLSI para teste de susceptibilidade a antifúngicos de isolados orais de Candida albicans
by: Cristiane Yumi Koga-Ito, et al.
Published: (2008-02-01)

Lack of Association between YEASTONE Antifungal Susceptibility Tests and Clinical Outcomes of <i>Cryptococcus</i> Meningitis
by: Ting-Shu Wu, et al.
Published: (2023-02-01)

Updated EUCAST Clinical Breakpoints against <i>Aspergillus</i>, Implications for the Clinical Microbiology Laboratory
by: Jesús Guinea
Published: (2020-12-01)

In Vitro Activity of Ibrexafungerp against a Collection of Clinical Isolates of <i>Aspergillus</i>, Including Cryptic Species and Cyp51A Mutants, Using EUCAST and CLSI Methodologies
by: Olga Rivero-Menendez, et al.
Published: (2021-03-01)

Discordance of vancomycin minimum inhibitory concentration for methicillin-resistant Staphylococcus aureus at 2 μg/mL between Vitek II, E-test, and Broth Microdilution
by: Chien-Feng Kuo, et al.
Published: (2020-05-01)

Evaluation of Etest and macrodilution broth method for antifungal susceptibility testing of Candida sp strains isolated from oral cavities of AIDS patients
by: SILVA Maria do Rosário R., et al.
Published: (2002-01-01)

A Pragmatic Approach to Susceptibility Classification of Yeasts without EUCAST Clinical Breakpoints
by: Karen Marie Thyssen Astvad, et al.
Published: (2022-01-01)

Adaptation and Validation of a Modified Broth Microdilution Method for Screening the Anti-Yeast Activity of Plant Phenolics in Apple and Orange Juice Models
by: Jan Staš, et al.
Published: (2024-07-01)

Standardisation of high throughput microdilution antifungal susceptibility testing for Candida albicans and Cryptococcus neoformans
by: Holly E. E. Floyd, et al.
Published: (2024-10-01)

First Confirmed Description of <i>Acremonium egyptiacum</i> from Greece and Molecular Identification of <i>Acremonium</i> and <i>Acremonium</i>-like Clinical Isolates
by: Michael Arabatzis, et al.
Published: (2024-09-01)

The evolution of antifungal therapy: Traditional agents, current challenges and future perspectives
by: Cássia Milena de Souza, et al.
Published: (2025-01-01)

Drug susceptibility testing of Mycobacterium tuberculosis by the broth microdilution method with 7H9 broth
by: Ahmet Yilmaz Coban, et al.
Published: (2004-02-01)

Evaluating EUCAST rapid antimicrobial susceptibility test from positive neonatal blood culture directly against the golden standard disc diffusion method in a tertiary hospital
by: Basma EL Emam, et al.
Published: (2024-11-01)

A Review of Antifungal Susceptibility Testing for Dermatophyte Fungi and It’s Correlation with Previous Exposure and Clinical Responses
by: Sidra Saleem Khan, et al.
Published: (2022-12-01)

Improving Turnaround Times for Routine Antimicrobial Sensitivity Testing Following European Committee on Antimicrobial Susceptibility Testing Methodology in Patients with Bacteraemia
by: Raewyn Edmondson, et al.
Published: (2024-11-01)

Current Perspectives of Antifungal Therapy: A Special Focus on <i>Candida auris</i>
by: Arumugam Ganeshkumar, et al.
Published: (2024-06-01)

Identification of antifungal peptides produced by Lactobacillus plantarum IS10 grown in the MRS broth
by: Muhialdin, Belal J., et al.
Published: (2016)

In vitro susceptibility testing of Fonsecaea pedrosoi to antifungals
by: Catalina de BEDOUT, et al.
Published: (1997-05-01)

Standartization of broth microdilution method for Mycobacterium tuberculosis
by: Clarice Queico Fujimura Leite, et al.
Published: (2000-01-01)

Isavuconazole—Animal Data and Clinical Data
by: Livio Pagano, et al.
Published: (2020-10-01)

Antifungals: From Pharmacokinetics to Clinical Practice
by: Anália Carmo, et al.
Published: (2023-05-01)